Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Monday 02 September, 2013

GlaxoSmithKline PLC

Total Voting Rights

RNS Number : 0038N
GlaxoSmithKline PLC
02 September 2013









Total Voting Rights and Capital


In conformity with Disclosure and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the Company) hereby notifies the market of the following:


The Company's issued share capital as at 30 August 2013 consisted of 5,413,579,513 Ordinary Shares of 25p each, of which 514,835,412 Ordinary Shares were held in Treasury.


Therefore, the total number of voting rights in the Company is 4,898,744,101. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.




S M Bicknell

Company Secretary


2 September 2013



This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t